Role of endogenous endothelin in the development of graft arteriosclerosis in rat cardiac allografts: Antiproliferative effects of bosentan, a nonselective endothelin receptor antagonist

Circulation

Volumn 97, Issue 23, 1998, Pages 2346-2351

  Okada, Kenji ^a   Nishida, Yasuhiro ^b   Murakami, Hiroshi ^b   Sugimoto, Isao ^b   Kosaka, Hiroaki ^b   Morita, Hironobu ^b   Yamashita, Chojiro ^b   Okada, Masayoshi ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b NONE

Author keywords

Arteriosclerosis; Coronary disease; Endothelin; Receptors; Transplantation

Indexed keywords

BOSENTAN; ENDOTHELIN 1;

ANIMAL EXPERIMENT; ARTERIOLOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; DRUG EFFECT; HEART TRANSPLANTATION; MALE; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT;

EID: 0032537526     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.97.23.2346     Document Type: Article

References (34)

1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclemsis. 1989;78:225-228.
3. Alberts GF, Peifley KA, Johns A, Kleha JF, Winkles JA. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem. 1994;269:10112-10118.
4. Koide M, Kawahara Y, Tsuda T, Ishida Y, Shii K, Yokoyama M, Stimulation of protein-tyrosine phosphorylation by endothelin-1 in cultured vascular smooth muscle cells. Atherosclerosis. 1992;92:1-7.
5. Wang Y, Rose PM, Webb ML, Dunn MJ. Endothelins stimulate mitogen-activated protein kinase cascade through either ETA or ETB. Am J Physiol. 1994;267:C1130-C1135.
6. Bobik A, Grooms A, Millar JA, Mitchell A, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol. 1990;258:C408-C415.
7. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett. 1988;238:249-252.
8. Alberts GF, Peifley KA, Johns A. Kleha JF, Winkles JA. Constitutive endothelin-1 overexpression promotes smooth muscle cell proliferation via an external autocrine loop. J Biol Chem. 1994;269:10112-10118.
9. Ohlstein EH, Arleth A, Bryan H, Elliott JD, Sung CP. The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis. Eur J Pharmacol. 1992;225:347-350.
10. Douglas SA, Louden C, Vickery Clark LM, Storer BL, Hart T, Feuerstein GZ, Elliott JD, Ohlstein EH. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty: protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. Circ Res. 1994;75:190-197.
11. Lerman A, Kubo SH, Tschumperlin LK, Burnett JC Jr. Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantation. J Am Coll Cardiol. 1992;20:849-853.
12. Lerman A, Click RL, Narr BJ, Wiesner RH, Krom RA, Textor SC, Burnett JC Jr. Elevation of plasma endothelin associated with systemic hypertension in humans following orthotopic liver transplantation. Transplantation. 1991;51:646-650.
13. Forbes RD, Cernacek P, Zheng S, Gomersall M, Guttmann RD. Increased endothelin expression in a rat cardiac allograft model of chronic vascular rejection. Transplantation. 1996;61:791-797.
14. Watschinger B, Sayegh MH, Hancock WW, Russell ME. Up-regulation of endothelin-1 mRNA and peptide expression in rat cardiac allografts with rejection and arteriosclerosis. Am J Pathol. 1995;146:1065-1072.
15. Ravalli S, Szabolcs M, Albala A, Michler RE, Cannon PJ. Increased immunoreactive endothelin-1 in human transplant coronary artery disease. Circulation. 1996;94:2096-2102.
16. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Loffler BM, Muller M, Neidhart W, Ramuz H. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature. 1993;365:759-761.
17. Clozel M, Breu V, Gray GA, Kalina B, Loffler BM, Burri K, Cassal JM, Hirth G, Muller M, Neidhart W, Ramuz H. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther. 1994;270:228-235.
18. Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 1969;57:225-229.
19. Lurie KG, Billingham ME, Jamieson SW, Harrison DC, Reitz BA. Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. Transplantation. 1981;31:41-47.
20. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Matsuda M, Hamashima Y, Kawai C. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation. 1987;75:1130-1139.
21. Vane JR, Änggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 1990;323:27-36.
22. Russell ME, Wallace AF, Hancock WW, Sayegh MH, Adams DH, Sibinga NE, Wyner LR, Kamovsky MJ. Upregulation of cytokines associated with macrophage activation in the Lewis-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation. 1995;59:572-578.
23. Adams DH, Russell ME, Hancock WW, Sayegh MH, Wyner LR, Karnovsky MJ. Chronic rejection in experimental cardiac transplantation: studies in the Lewis-F344 model. Immunol Rev. 1993;134:5-19.
24. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-α. Am J Physiol. 1992;262:C854-C861.
25. Maemura K, Kurihara H, Morita T, Oh-hashi Y, Yazaki Y. Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology. 1992;38:29-35.
26. Endo T, Uchida Y, Matsumoto H, Suzuki N, Nomura A, Hirata F, Hasegawa S. Regulation of endothelin-1 synthesis in cultured guinea pig airway epithelial cells by various cytokines. Biochem Biophys Res Commun. 1992;186:1594-1599.
27. Brown MR, Vaughan J, Jimenez LL, Vale W, Baird A. Transforming growth factor-β: role in mediating serum-induced endothelin production by vascular endothelial cells. Endocrinology. 1991;129:2355-2360.
28. Zoja C, Furci L, Ghilardi F, Zilio P, Benigni A, Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 1986;55:455-462.
29. Abassi ZA, Pieruzzi F, Nakhoul F, Keiser HR. Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat. Hypertension. 1996;27:1140-1148.
30. Bunchman TE, Brookshire CA. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest. 1991;88:310-314.
31. Edwards BS, Hunt SA, Fowler MB, Valantine HA, Anderson LM, Lerman A. Effect of cyclosporine on plasma endothelin levels in humans after cardiac transplantation. Am J Cardiol. 1991;67:782-784.
32. Forslund T, Hannonen P, Reitamo S, Fyhrquist F. Hypertension in cyclosporin A-treated patients is independent of circulating endothelin levels. J Intern Med. 1995;238:71-75.
33. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension. 1992;19:753-757.
34. Carratu P, Scuri M, Styblo JL, Wanner A, Glassberg MK. ET-1 induced mitogenesis in ovine airway smooth muscle cells via ETA and ETB receptors. Am J Physiol. 1997;272:L1021-L1024.